MedPath
HSA Approval

GLIOTEN 20 TABLET 20 mg

SIN12413P

GLIOTEN 20 TABLET 20 mg

GLIOTEN 20 TABLET 20 mg

August 30, 2003

ZYFAS PHARMA PTE LTD

ZYFAS PHARMA PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantZYFAS PHARMA PTE LTD
Licence HolderZYFAS PHARMA PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

TABLET

ORAL

Medical Information

C09AA02

enalapril

Manufacturer Information

ZYFAS PHARMA PTE. LTD.

LABORATORIOS BAGO SA

Active Ingredients

ENALAPRIL MALEATE

20 mg

Enalapril

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

GLIOTEN 20 TABLET 20 mg - HSA Approval | MedPath